These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

282 related articles for article (PubMed ID: 19237607)

  • 1. NDRG2 expression decreases with tumor stages and regulates TCF/beta-catenin signaling in human colon carcinoma.
    Kim YJ; Yoon SY; Kim JT; Song EY; Lee HG; Son HJ; Kim SY; Cho D; Choi I; Kim JH; Kim JW
    Carcinogenesis; 2009 Apr; 30(4):598-605. PubMed ID: 19237607
    [TBL] [Abstract][Full Text] [Related]  

  • 2. NDRG2 and PRA1 interact and synergistically inhibit T-cell factor/β-catenin signaling.
    Kim JT; Kim JW; Kang YH; Kim KD; Lee SJ; Choi SC; Kim KS; Chae SK; Kim JW; Lim JS; Lee HG
    FEBS Lett; 2012 Nov; 586(22):3962-8. PubMed ID: 23068607
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Sox7 Is an independent checkpoint for beta-catenin function in prostate and colon epithelial cells.
    Guo L; Zhong D; Lau S; Liu X; Dong XY; Sun X; Yang VW; Vertino PM; Moreno CS; Varma V; Dong JT; Zhou W
    Mol Cancer Res; 2008 Sep; 6(9):1421-30. PubMed ID: 18819930
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Downregulation of tumor suppressor Pdcd4 promotes invasion and activates both beta-catenin/Tcf and AP-1-dependent transcription in colon carcinoma cells.
    Wang Q; Sun Z; Yang HS
    Oncogene; 2008 Mar; 27(11):1527-35. PubMed ID: 17828298
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Low-grade slightly elevated and polypoid colorectal adenomas display differential β-catenin-TCF/LEF activity, c-Myc, and cyclin D1 expression.
    Yang TW; Gao YH; Ma SY; Wu Q; Li ZF
    World J Gastroenterol; 2017 May; 23(17):3066-3076. PubMed ID: 28533663
    [TBL] [Abstract][Full Text] [Related]  

  • 6. SPDEF Induces Quiescence of Colorectal Cancer Cells by Changing the Transcriptional Targets of β-catenin.
    Lo YH; Noah TK; Chen MS; Zou W; Borras E; Vilar E; Shroyer NF
    Gastroenterology; 2017 Jul; 153(1):205-218.e8. PubMed ID: 28390865
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Tumor suppressor NDRG2 inhibits glycolysis and glutaminolysis in colorectal cancer cells by repressing c-Myc expression.
    Xu X; Li J; Sun X; Guo Y; Chu D; Wei L; Li X; Yang G; Liu X; Yao L; Zhang J; Shen L
    Oncotarget; 2015 Sep; 6(28):26161-76. PubMed ID: 26317652
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Regulation of β-catenin by t-DARPP in upper gastrointestinal cancer cells.
    Vangamudi B; Zhu S; Soutto M; Belkhiri A; El-Rifai W
    Mol Cancer; 2011 Mar; 10():32. PubMed ID: 21447180
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Sox17 and Sox4 differentially regulate beta-catenin/T-cell factor activity and proliferation of colon carcinoma cells.
    Sinner D; Kordich JJ; Spence JR; Opoka R; Rankin S; Lin SC; Jonatan D; Zorn AM; Wells JM
    Mol Cell Biol; 2007 Nov; 27(22):7802-15. PubMed ID: 17875931
    [TBL] [Abstract][Full Text] [Related]  

  • 10. ITF2 prevents activation of the β-catenin-TCF4 complex in colon cancer cells and levels decrease with tumor progression.
    Shin HW; Choi H; So D; Kim YI; Cho K; Chung HJ; Lee KH; Chun YS; Cho CH; Kang GH; Kim WH; Park JW
    Gastroenterology; 2014 Aug; 147(2):430-442.e8. PubMed ID: 24846398
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Ionomycin downregulates beta-catenin/Tcf signaling in colon cancer cell line.
    Park CH; Hahm ER; Lee JH; Jung KC; Rhee HS; Yang CH
    Carcinogenesis; 2005 Nov; 26(11):1929-33. PubMed ID: 15930030
    [TBL] [Abstract][Full Text] [Related]  

  • 12. TIS7 regulation of the beta-catenin/Tcf-4 target gene osteopontin (OPN) is histone deacetylase-dependent.
    Vietor I; Kurzbauer R; Brosch G; Huber LA
    J Biol Chem; 2005 Dec; 280(48):39795-801. PubMed ID: 16204248
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Wnt/β-catenin signaling pathway is a direct enhancer of thyroid transcription factor-1 in human papillary thyroid carcinoma cells.
    Gilbert-Sirieix M; Makoukji J; Kimura S; Talbot M; Caillou B; Massaad C; Massaad-Massade L
    PLoS One; 2011; 6(7):e22280. PubMed ID: 21814573
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Elevated protein expression of cyclin D1 and Fra-1 but decreased expression of c-Myc in human colorectal adenocarcinomas overexpressing beta-catenin.
    Wang HL; Wang J; Xiao SY; Haydon R; Stoiber D; He TC; Bissonnette M; Hart J
    Int J Cancer; 2002 Oct; 101(4):301-10. PubMed ID: 12209953
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Regulation of the versican promoter by the beta-catenin-T-cell factor complex in vascular smooth muscle cells.
    Rahmani M; Read JT; Carthy JM; McDonald PC; Wong BW; Esfandiarei M; Si X; Luo Z; Luo H; Rennie PS; McManus BM
    J Biol Chem; 2005 Apr; 280(13):13019-28. PubMed ID: 15668231
    [TBL] [Abstract][Full Text] [Related]  

  • 16. HEF1, a novel target of Wnt signaling, promotes colonic cell migration and cancer progression.
    Li Y; Bavarva JH; Wang Z; Guo J; Qian C; Thibodeau SN; Golemis EA; Liu W
    Oncogene; 2011 Jun; 30(23):2633-43. PubMed ID: 21317929
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Suppression of N-myc downstream-regulated gene 2 is associated with induction of Myc in colorectal cancer and correlates closely with differentiation.
    Shi H; Jin H; Chu D; Wang W; Zhang J; Chen C; Xu C; Fan D; Yao L
    Biol Pharm Bull; 2009 Jun; 32(6):968-75. PubMed ID: 19483300
    [TBL] [Abstract][Full Text] [Related]  

  • 18. TCF 4 tumor suppressor: a molecular target in the prognosis of sporadic colorectal cancer in humans.
    Anwar M; Malhotra P; Kochhar R; Bhatia A; Mahmood A; Singh R; Mahmood S
    Cell Mol Biol Lett; 2020; 25():24. PubMed ID: 32265994
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Downregulation of E-cadherin is an essential event in activating beta-catenin/Tcf-dependent transcription and expression of its target genes in Pdcd4 knockdown cells.
    Wang Q; Sun ZX; Allgayer H; Yang HS
    Oncogene; 2010 Jan; 29(1):128-38. PubMed ID: 19784072
    [TBL] [Abstract][Full Text] [Related]  

  • 20. OVOL2, an Inhibitor of WNT Signaling, Reduces Invasive Activities of Human and Mouse Cancer Cells and Is Down-regulated in Human Colorectal Tumors.
    Ye GD; Sun GB; Jiao P; Chen C; Liu QF; Huang XL; Zhang R; Cai WY; Li SN; Wu JF; Liu YJ; Wu RS; Xie YY; Chan EC; Liou YC; Li BA
    Gastroenterology; 2016 Mar; 150(3):659-671.e16. PubMed ID: 26619963
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.